• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.64% Nasdaq Up 1.86%

    ImmunoCellular Therapeutics, Ltd. (IMUC)

    -NYSE MKT
    0.23 Down 0.00(1.89%) Jun 29, 4:02PM EDT
    Prev Close:0.24
    Open:0.23
    Bid:0.23 x 300
    Ask:0.24 x 600
    1y Target Est:2.50
    Beta:0.9469
    Earnings Date:Aug 4 - Aug 8 (Est.)
    Day's Range:0.23 - 0.24
    52wk Range:0.20 - 0.64
    Volume:53,600
    Avg Vol (3m):338,072
    Market Cap:21.72M
    P/E (ttm):N/A
    EPS (ttm):-0.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IMUC

    Comparison

    Symbol% ChgMkt Cap
    IMUCDown 1.89%21.72M
    STMLDown 0.59%129.31M
    AGENUp 2.32%344.91M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.27
    Quarterly EPS Est (Jun-16) :-0.07
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback